David Estapé, Chair of the 2026 ISPE Europe Annual Conference, provides an overview of how this year’s conference—to be held 20–22 April in Copenhagen, Denmark, and virtually—was designed to truly reflect the current pulse of the pharmaceutical...
To deliver meaningful value, a conference must truly reflect the current pulse of the pharmaceutical industry. This is easier said than done, as the sector is undergoing a profound and multifaceted transformation.
Biopharmaceutical facility design is a critical aspect of the industry. Overall cost pressures in the global health system, regional requirements to deploy manufacturing rather than centralize manufacturing in one location, technology enhancements in cell biology and format, flexibility to accommodate multi-product campaigns with different production schedules, and speed-to-market are among...
Following the recent surge in popularity of mRNA technology due to Covid-19 vaccines, we are beginning to realise its impact and potential in this field and for oligonucleotides. However, we face a steep learning curve in understanding the diversity and specifics of the manufacturing chain that make this new generation of RNA drug products completely different from traditional biologics (e.g....
